• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×
  • 02 Jun 17
title

Most popular equity research this week | 29-2 June

  • 961 views
James Valentine

Digital editor at Research Tree

 
Mac Trending
Strap line

See what was trending this week...

Companies: ABZA, BVXP, CTH, FSJPF, MTFB, OPTI, PLUS, RTHM, 0RYA, SDXEF, STR, TEF


Body

Featured Report:

Rude Health

Abzena, AKERS BIOSCIENCES INC, Allergy Therapeutics, Alliance Pharma, Avacta, Bioventix, Byotrol, Cambridge Cognition Holdings, Caretech Holdings, Lidco, Motif Bio, Omega Diagnostics, OptiBiotix Health, Premaitha Health, Proteome Sciences, Scientific Digital Imaging, Tristel,


Pharma

 

“Sell in May and go away” – this certainly does not apply to a number of companies, for which significant data points and milestones are expected to occur over the next few months. We highlight the following: Alliance Pharma (APH) – UK approval of Diclectin for Nausea and Vomiting of Pregnancy; Abzena (ABZA) – Phase II/III readout for two Abzena Inside antibodies; Avacta (AVCT) – multiple data points during Q3; ANGLE (AGL) – headline data for Parsortix in ovarian cancer; and, perhaps most significant, the Phase III readout from Motif Bio's (MTFB) REVIVE-2 study for iclaprim, which we expect to be positive and lead to the company filing with the FDA in 2017.... read more



Very strong trading update, buyback launched

Plus500 (PLUS) | Liberum, 2 June

Gold Access

 

"Today's trading update indicates that the positive momentum seen in Q1 continued into Q2, suggesting risk to consensus forecasts is strongly to the upside. So far there has been no impact to business from the proposed regulatory changes in Plus's markets..." 

 

 

Consistent execution
RhythmOne (RTHM) | N+1 Singer, 30 May

Gold Access

 

"Good execution has driven a huge profit turnaround. A $10.5m EBITDA for FY16 became a profit of $3.9m in H2’FY17. The business is now simpler after exiting all non-core activity and focusing on areas of market growth with a high quality integrated offering and strong technology platform. International expansion was successfully launched during the year. There are 15 markets operating and delivering 10% of core programmatic revenues. The quality and scale of the offering makes the Company a compelling partner and this has led to a boost in new partners and publishers. With the existing business having moved into profit, International expansion working very well and the Perk acquisition set to contribute in FY18, the Company looks set to deliver a substantial leap in EBITDA (we forecast $15.2m) and generate material cash. The Company is confident about trading trends and we see it as just a matter of time before another scale/product orientated deal. The stock is responding to execution and has risen 19.1% since we initiated with BUY. We lift our TP to 70p, maintain our BUY and flag the stock continues to warrant a place in our Best Ideas portfolio..."

 


Increasing TP to €20

Ryanair Holdings (RYA) | Panmure Gordon, 31 May

Gold Access

 

"Intra-Europe traffic growth of MSD% p.a. looks well grounded, and Ryanair is in a (probably the) leading position to capitalise on increasing commoditisation of the short-haul market as the industry consolidates. We now model €1bn p.a. share buybacks, increasing FY18/19 EPS by 4/12%, and raise our TP to €20. BUY..." 

 


Strongly resilient and now loaded with international and connected spirit

Ryanair Holdings (RYA) | AlphaValue, 31 May

Gold Access

 

"Ryanair surprised once again by its strong ability for resilience even in a difficult environment (specifically following the Brexit vote) when average fares strongly declined (-13%). It confirmed its capacity to reduce even further its operating costs (though low oil prices helped quite a lot) while increasing its load factor to an industry leading 94% and its number of passenger to 120m, while it expects 130m for next year. Capacity is not expected to grow quickly enough for Ryanair as it is looking for additional aircraft deliveries in the next 24 months with Boeing. This enables the Irish airline to look at other airlines’ market shares, like that of Alitalia or Air Berlin which might need to cease operating on some routes. Finally, partnerships that it aims to sign with low-cost long-haul airlines should establish even more its European leading market share (15%)..."

 

 

Confirmation of significant discovery
SDX ENERGY INC (SDX) | Edison, 31 May

Free Access

 

"SDX Energy has announced the initial results of the testing at the SD-1X gas discovery in the South Disouq licence where it has a 55% operated working interest. The initial test produced a flow rate of dry gas of 25.8 mmcf/day which was ahead of management expectations of approximately 15 mmcf/day. This flow rate was limited by the surface equipment. The well has now been shut in for initial build up and then will be flow tested at several additional flow rates and fluid samples taken in order to gather data to allow the management to proceed with a development plan..." 

 


Robust growth in real money gaming

Stride Gaming (STR) | Edison, 30 May

Free Access

 

"Stride Gaming’s H117 pro forma net gaming revenues (NGR) grew 21% to £44.0m, driven by strong organic growth in the real money gaming (RMG) vertical. In a continuation of previous trends, the social gaming vertical has weakened, with a 24% decline in revenues to £4.7m, and Stride has recognised a £10.2m impairment on its InfiApps assets. However, the core RMG business is gaining market share, trading has been robust in Q317 and management has reiterated its FY17 outlook. Our headline FY17 revenue and EBITDA figures remain unchanged. Stride trades at 7.5x calendar 2017e EV/EBITDA, a meaningful discount to its peers..."

 


Making capital in London

Telford Homes (TEF) | Equity Development, 31 May

Free Access

 

"Telford Homes has published another positive set of full year results with record revenues and profits. The company has a large development pipeline, it enjoys excellent visibility through its forward order book and the balance sheet is robust. We expect continued growth over the next three years..." 

 


Major turnaround taking shape

Fastjet (FJET) | Equity Development, 1 June

Free Access

 

"Investing in airlines has always been a hazardous game, given the industry’s notoriously poor record of capital allocation, cyclicality and exposure to geopolitics, terrorism and the oil price. The former contributing towards the eye-watering bankruptcies at Sir Freddie Laker’s SkyTrain and PanAm back in the 1980/90s, in addition to US, Northwest and American airlines post 2000. Worse still, carriers are today right in the cross-hairs when things go wrong, as demonstrated by British Airways’ public relations fiasco at Heathrow and Gatwick last weekend. Nonetheless, real improvements are being made, with stronger management forcing through capital discipline and more flexible cost structures, alongside greater demand from emerging market tourists, who are increasingly opting to travel abroad..."


Body Two

Body Three

Body Four

Body Five

The information contained within this post is based on personal experience and opinion and should not be considered as a recommendation to trade nor financial advice.

More Content

More Content

PANMURE LIBERUM: Plus500: Strong momentum heading into H2

Companies: Plus500 Ltd.

Panmure Liberum

Most popular equity research this week | 9 - 13 Oct

Companies: 600258BTRWBWYVTYIOMLGENPSNTW/CCTIQETEFBKGPHDINLWEYCRSTWJGFLOFEVRGLEEHGW7LJOGMCSCSPPURPABBYCRNPLUSRDWWFHCMNEXNXPPDGNYF

Research Tree

Cryptocurrencies 28 July 2025

Companies: ALNEV IOTC BTSC BTGN NMOC NLTX NMRD NEOD NEO NBCO NEOL NEOG NEN NMT SRZ NEO 1868 NEOE3 BTCT ADE NPTN PNG NNE NEO NVC NEM NBM BTCW KLH SPX NEM NEON NMGC NEOLA NEO NGL NEOM NMX BNDI NEOS MLNLF NELR ALNLF NCI NEM 6922 NEO STEL TLTI IAUI NEO PLUS NEOGEN NEOL STCS NGI NEO NSP NTX 950220 3921 NEOH 042420 085910 092730 094860 095660 212560 253590 290660 306620 311390 ETOR NEON QBTC NTMC NEOFI NPFL NLC NGRD3 NDT NEOG NEMYSIS NEM 172A BTCI NMGC NEOBO IWMI 4196 SVCCU IYRI COINXBT NTHI HYBI ZVNS 4131 SPYI ALNEV BTGN STEL QQQH NBCO NEOM NTGN NEOV BTM NMRD NEOB CSHI CASL NEMAKA QQQI SPYH

Acquisdata

Most popular equity research this week | 8 Jan - 12 Jan

Companies: BTRWBWYVTYLWBPSNTW/AVGTEFBKGSTAFHATINLCRSTWJGSPRGLETUNEEHGMCSCSPBURABBYCRNDEBSRDWWF

Research Tree

PANMURE LIBERUM: Plus500: A focus on quality growth

Companies: Plus500 Ltd.

Panmure Liberum
next
 
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
  • LLM Feed
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In